✦ LIBER ✦

Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for the Prevention of Stroke: An Analysis of Patients with Atrial Fibrillation in Greece

✍ Scribed by Athanasakis, K.; Arzoumanidou, D.; Karampli, E.; Armelidou, E.; Giovas, P.; Petrikkou, E.; Kyriopoulos, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Apixaban Versus Ot

✍ Lip, Gregory Y.H.; Kongnakorn, Thitima; Phatak, Hemant; Kuznik, Andreas; Lanitis 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 904 KB

Cost-Effectiveness of Apixaban Versus St

✍ Athanasakis, K.; Arzoumanidou, D.; Karampli, E.; Armelidou, E.; Giovas, P.; Petr 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Cost-effectiveness of new oral anticoagu

✍ Kansal, Anuraag R.; Zheng, Ying; Pokora, Tiffany; Sorensen, Sonja V. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 277 KB

Cost-Effectiveness Analysis of Apixaban

✍ Betegón Nicolás, L.; Escolar Albaladejo, G.; Canal Fontcuberta, C.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Cost-Effectiveness Analysis of Apixaban

✍ Canal Fontcuberta, C.; Escolar Albaladejo, G.; Betegón Nicolás, L.; de Salas-Can 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Stroke prevention in patients with atria

✍ Lanitis, T.; Cotté, F. E.; Gaudin, A. F.; Kachaner, I.; Kongnakorn, T.; Durand-Z 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 611 KB